The NRAMP1, VDR, TNF-α, ICAM1, TLR2 and TLR4 gene polymorphisms in Iranian patients with pulmonary tuberculosis: A case-control study

Infection, Genetics and Evolution

Volumn 39, Issue , 2016, Pages 92-98

  Jafari, Mohammad ^a,b   Nasiri, Mohammad Reza ^a   Sanaei, Roozbeh ^a   Anoosheh, Saber ^c,d   Farnia, Parisa ^c   Sepanjnia, Adel ^a   Tajik, Nader ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

ARMS PCR; Association study; Gene polymorphism; Iran; Pulmonary tuberculosis

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; CATION TRANSPORT PROTEIN; ICAM1 PROTEIN, HUMAN; NATURAL RESISTANCE-ASSOCIATED MACROPHAGE PROTEIN 1; TLR2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN; TNF PROTEIN, HUMAN; TUMOR NECROSIS FACTOR; VDR PROTEIN, HUMAN;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; HUMAN; ICAM1 GENE; IRANIAN PEOPLE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; NRAMP1 GENE; PATHOGENESIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TLR2 GENE; TLR4 GENE; TNF ALPHA GENE; VDR GENE; AGED; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; IRAN; MIDDLE AGED; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CATION TRANSPORT PROTEINS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, INNATE; INTERCELLULAR ADHESION MOLECULE-1; IRAN; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCITRIOL; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84955126012     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2016.01.013     Document Type: Article

References (72)

1. Abel B., Thieblemont N., Quesniaux V.J., Brown N., Mpagi J., Miyake K., Bihl F., Ryffel B. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J. Immunol. 2002, 169(6):3155-3162.
2. Afzal S., Bojesen S.E., Nordestgaard B.G. Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysis. Clin. Chem. 2013, 59(2):381-391.
3. Ahmad S. Pathogenesis, immunology, and diagnosis of latent Mycobacterium tuberculosis infection. Clin. Dev. Immunol. 2010, 2011.
4. Amirzargar A.A., Rezaei N., Jabbari H., Danesh A.A., Khosravi F., Hajabdolbaghi M., Yalda A., Nikbin B. Cytokine single nucleotide polymorphisms in Iranian patients with pulmonary tuberculosis. Eur. Cytokine Netw. 2006, 17(2):84-89.
5. Arbour N.C., Lorenz E., Schutte B.C., Zabner J., Kline J.N., Jones M., Frees K., Watt J.L., Schwartz D.A. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 2000, 25(2):187-191.
6. Arji N., Busson M., Iraqi G., Bourkadi J.E., Benjouad A., Bouayad A., Mariaselvam C., Salah S., Fortier C., Amokrane K. Genetic diversity of TLR2, TLR4, and VDR loci and pulmonary tuberculosis in Moroccan patients. J. Infect. Dev. Ctries. 2014, 8(04):430-440.
7. Ates Ö., Musellim B., Ongen G., Topal-Sarikaya A. Interleukin-10 and tumor necrosis factor-α gene polymorphisms in tuberculosis. J. Clin. Immunol. 2008, 28(3):232-236.
8. Ates Ö., Dalyan L., Müsellim B., Hatemi G., Türker H., Öngen G., Hamuryudan V., Topal-Sarikaya A. NRAMP1 (SLC11A1) gene polymorphisms that correlate with autoimmune versus infectious disease susceptibility in tuberculosis and rheumatoid arthritis. Int. J. Immunogenet. 2009, 36(1):15-19.
9. Azad A.K., Sadee W., Schlesinger L.S. Innate immune gene polymorphisms in tuberculosis. Infect. Immun. 2012, 80(10):3343-3359.
10. Babb C., Van Der Merwe L., Beyers N., Pheiffer C., Walzl G., Duncan K., Van Helden P., Hoal E. Vitamin D receptor gene polymorphisms and sputum conversion time in pulmonary tuberculosis patients. Tuberculosis 2007, 87(4):295-302.
11. Bai R., Yi S., Zhang X., Liu H., Fang X. Role of ICAM-1 polymorphisms (G241R, K469E) in mediating its single-molecule binding ability: atomic force microscopy measurements on living cells. Biochem. Biophys. Res. Commun. 2014, 448(4):372-378.
12. Banoei M.M., Mirsaeidi M.S., Houshmand M., Tabarsi P., Ebrahimi G., Zargari L., Kashani B.H., Masjedi M.R., Mansouri S.D., Ramirez J. Vitamin D receptor homozygote mutant tt and bb are associated with susceptibility to pulmonary tuberculosis in the Iranian population. Int. J. Infect. Dis. 2010, 14(1):e84-e85.
13. Barton C.H., Whitehead S.H., Blackwell J.M. Nramp transfection transfers Ity/Lsh/Bcg-related pleiotropic effects on macrophage activation: influence on oxidative burst and nitric oxide pathways. Mol. Med. 1995, 1(3):267.
14. Barton C.H., Biggs T.E., Baker S.T., Bowen H., Atkinson P. Nramp1: a link between intracellular iron transport and innate resistance to intracellular pathogens. J. Leukoc. Biol. 1999, 66(5):757-762.
15. Bellamy R., Ruwende C., Corrah T., McAdam K.P., Whittle H.C., Hill A.V. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N. Engl. J. Med. 1998, 338(10):640-644.
16. Ben-Ali M., Barbouche M.-R., Bousnina S., Chabbou A., Dellagi K. Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin. Diagn. Lab. Immunol. 2004, 11(3):625-626.
17. Ben-Selma W., Harizi H., Boukadida J. Association of TNF-α and IL-10 polymorphisms with tuberculosis in Tunisian populations. Microbes Infect. 2011, 13(10):837-843.
18. Bhalla K., Chugh M., Mehrotra S., Rathore S., Tousif S., Dwivedi V.P., Prakash P., Samuchiwal S.K., Kumar S., Singh D.K. Host ICAMs play a role in cell invasion by Mycobacterium tuberculosis and Plasmodium falciparum. Nat. Commun. 2015, 6.
19. Biswas S., Kar S., Singh R., Chakraborty D., Vipat V., Raut C., Mishra A., Gore M., Ghosh D. Immunomodulatory cytokines determine the outcome of Japanese encephalitis virus infection in mice. J. Med. Virol. 2010, 82(2):304-310.
20. Blackwell J.M., Barton C.H., White J.K., Searle S., Baker A.-M., Williams H., Shaw M.-A. Genomic organization and sequence of the human NRAMP gene: identification and mapping of a promoter region polymorphism. Mol. Med. 1995, 1(2):194.
21. Chen C., Liu Q., Zhu L., Yang H., Lu W. Vitamin D receptor gene polymorphisms on the risk of tuberculosis, a meta-analysis of 29 case-control studies. PLoS One 2013, 8(12).
22. Cheng P.-L., Eng H.-L., Chou M.-H., You H.-L., Lin T.-M. Genetic polymorphisms of viral infection-associated Toll-like receptors in Chinese population. Transl. Res. 2007, 150(5):311-318.
23. Chun R.F., Adams J.S., Hewison M. Back to the future: a new look at 'old' vitamin D. J. Endocrinol. 2008, 198(2):261-269.
24. Comstock G.W. Tuberculosis in twins: a re-analysis of the Prophit survey. Am. Rev. Respir. Dis. 1978, 117(4):621-624.
25. Correa P.A., Gomez L.M., Anaya J.M. [Polymorphism of TNF-alpha in autoimmunity and tuberculosis]. Biomedica 2004, 24(Supp 1):43-51.
26. Correa P.A., Gomez L.M., Cadena J., Anaya J.M. Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J. Rheumatol. 2005, 32(2):219-224.
27. Dye C., Scheele S., Dolin P., Pathania V., Raviglione M. WHO global surveillance and monitoring project. Consensus Statement. Global burden of tuberculosis. Estimated incidence, prevalence and mortality by country. JAMA 1999, 282:677-686.
28. Ferwerda B., Kibiki G.S., Netea M.G., Dolmans W.M., van der Ven A.J. The toll-like receptor 4 Asp299Gly variant and tuberculosis susceptibility in HIV-infected patients in Tanzania. AIDS 2007, 21(10):1375-1377.
29. Gao L., Tao Y., Zhang L., Jin Q. Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis [review article]. Int. J. Tuberc. Lung Dis. 2010, 14(1):15-23.
30. Gruenheid S., Pinner E., Desjardins M., Gros P. Natural resistance to infection with intracellular pathogens: the Nramp1 protein is recruited to the membrane of the phagosome. J. Exp. Med. 1997, 185(4):717-730.
31. Gupta V., Sehajpal P.K. Rapid detection of single nucleotide (-308) polymorphism in TNF-alpha promoter using ARMS-PCR. Curr. Sci. 2003, 85(11):1521-1523.
32. Handono K., Marisa D., Kalim H. Association between the low levels of vitamin D and Treg function in systemic lupus erythematosus patients. Acta Med. Indones. 2013, 45:26-31.
33. Hoal E., Lewis L., Jamieson S., Tanzer F., Rossouw M., Victor T., Hillerman R., Beyers N., Blackwell J., Van Helden P. SLC11A1 (NRAMP1) but not SLC11A2 (NRAMP2) polymorphisms are associated with susceptibility to tuberculosis in a high-incidence community in South Africa. Int. J. Tuberc. Lung Dis. 2004, 8(12):1464-1471.
34. Huang J.H., Oefner P.J., Adi V., Ratnam K., Ruoss S.J., Trako E., Kao P.N. Analyses of the NRAMP1 and IFN-γ R1 genes in women with Mycobacterium avium-intracellulare pulmonary disease. Am. J. Respir. Crit. Care Med. 1998, 157(2):377-381.
35. Jin L., Ding S.-P., Zhu X.-F., Zhong J.-P., Li J.-C. The Arg753Gln polymorphism of the human Toll-like receptor 2 gene and its association with tuberculosis disease in Zhejiang Han population. Chin. J. Cell Biol. 2007, 29:229-231.
36. Karupiah G., Hunt N., King N., Chaudhri G. NADPH oxidase, Nramp1 and nitric oxide synthase 2 in the host antimicrobial response. Rev. Immunogenet. 1999, 2(3):387-415.
37. Kroeger K.M., Carville K.S., Abraham L.J. The -308 tumor necrosis factor-α promoter polymorphism effects transcription. Mol. Immunol. 1997, 34(5):391-399.
38. Leandro A., Rocha M., Cardoso C., Bonecini-Almeida M. Genetic polymorphisms in vitamin D receptor, vitamin D-binding protein, Toll-like receptor 2, nitric oxide synthase 2, and interferon-γ genes and its association with susceptibility to tuberculosis. Braz. J. Med. Biol. Res. 2009, 42(4):312-322.
39. Li H., Zhang T., Zhou Y., Huang Q., Huang J. SLC11A1 (formerly NRAMP1) gene polymorphisms and tuberculosis susceptibility: a meta-analysis [review article]. Int. J. Tuberc. Lung Dis. 2006, 10(1):3-12.
40. Liu P.T., Stenger S., Tang D.H., Modlin R.L. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J. Immunol. 2007, 179(4):2060-2063.
41. Lombard Z., Dalton D.L., Venter P.A., Williams R.C., Bornman L. Association of HLA-DR, -DQ, and vitamin D receptor alleles and haplotypes with tuberculosis in the Venda of South Africa. Hum. Immunol. 2006, 67(8):643-654.
42. Long R., Gardam M. Tumour necrosis factor-α inhibitors and the reactivation of latent tuberculosis infection. Can. Med. Assoc. J. 2003, 168(9):1153-1156.
43. Lorenz E., Mira J.P., Frees K.L., Schwartz D.A. Relevance of mutations in the TLR4 receptor in patients with Gram-negative septic shock. Arch. Intern. Med. 2002, 162(9):1028-1032.
44. Medzhitov R., Preston-Hurlburt P., Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388(6640):394-397.
45. Merza M., Farnia P., Anoosheh S., Varahram M., Kazampour M., Pajand O., Saeif S., Mirsaeidi M., Masjedi M.R., Velayati A.A. The NRAMPI, VDR and TNF-α gene polymorphisms in Iranian tuberculosis patients: the study on host susceptibility. Braz. J. Infect. Dis. 2009, 13(4):252-256.
46. Miller S., Dykes D., Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988, 16(3):1215.
47. Naderi M., Hashemi M., Hazire-Yazdi L., Taheri M., Moazeni-Roodi A., Eskandari-Nasab E., Bahari G. Association between toll-like receptor2 Arg677Trp and 597T/C gene polymorphisms and pulmonary tuberculosis in Zahedan, Southeast Iran. Braz. J. Infect. Dis. 2013, 17(5):516-520.
48. Najmi N., Kaur G., Sharma S., Mehra N. Human Toll-like receptor 4 polymorphisms TLR4 Asp299Gly and Thr399Ile influence susceptibility and severity of pulmonary tuberculosis in the Asian Indian population. Tissue Antigens 2010, 76(2):102-109.
49. Newport M., Allen A., Awomoyi A.A., Dunstan S., McKinney E., Marchant A., Sirugo G. The toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or susceptibility to pulmonary tuberculosis in the Gambia. Tuberculosis 2004, 84(6):347-352.
50. Niño-Moreno P., Portales-Pérez D., Hernández-Castro B., Portales-Cervantes L., Flores-Meraz V., Baranda L., Gómez-Gómez A., Acuña-Alonzo V., Granados J., González-Amaro R. P2X7 and NRAMP1/SLC11 A1 gene polymorphisms in Mexican mestizo patients with pulmonary tuberculosis. Clin. Exp. Immunol. 2007, 148(3):469-477.
51. Nnoaham K.E., Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int. J. Epidemiol. 2008, 37(1):113-119.
52. Ogus A., Yoldas B., Ozdemir T., Uguz A., Olcen S., Keser I., Coskun M., Cilli A., Yegin O. The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Eur. Respir. J. 2004, 23(2):219-223.
53. Pujhari S.K., Ratho R.K., Prabhakar S., Mishra B., Modi M. TNF-α promoter polymorphism: a factor contributing to the different immunological and clinical phenotypes in Japanese encephalitis. BMC Infect. Dis. 2012, 12(1):23.
54. Rashedi J., Asgharzadeh M., Moaddab S.R., Sahebi L., Khalili M., Mazani M., Abdolalizadeh J. Vitamin D receptor gene polymorphism and vitamin D plasma concentration: Correlation with susceptibility to tuberculosis. Adv Pharm Bull. 2014, 4(Suppl 2):607-611.
55. Rosas-Taraco A.G., Revol A., Salinas-Carmona M.C., Rendon A., Caballero-Olin G., Arce-Mendoza A.Y. CD14 C (-159) T polymorphism is a risk factor for development of pulmonary tuberculosis. J. Infect. Dis. 2007, 196(11):1698-1706.
56. Sanchez D., Lefebvre C., Rioux J., Garcia L.F., Barrera L.F. Evaluation of Toll-like receptor and adaptor molecule polymorphisms for susceptibility to tuberculosis in a Colombian population. Int. J. Immunogenet. 2012, 39(3):216-223.
57. Sandhya P., Danda S., Danda D., Lonarkar S., Luke S.S., Sinha S., Joseph G. Tumour necrosis factor (TNF)-α-308 gene polymorphism in Indian patients with Takayasu's arteritis - a pilot study. Indian J. Med. Res. 2013, 137(4):749.
58. Schröder N.W., Hermann C., Hamann L., Göbel U.B., Hartung T., Schumann R.R. High frequency of polymorphism Arg753Gln of the Toll-like receptor-2 gene detected by a novel allele-specific PCR. J. Mol. Med. 2003, 81(6):368-372.
59. Selvaraj P. Host genetics and tuberculosis susceptibility. Curr. Sci. 2004, 86(1):115-121.
60. Selvaraj P., Harishankar M., Singh B., Jawahar M., Banurekha V. Toll-like receptor and TIRAP gene polymorphisms in pulmonary tuberculosis patients of south India. Tuberculosis 2010, 90(5):306-310.
61. Soborg C., Andersen A.B., Madsen H.O., Kok-Jensen A., Skinhoj P., Garred P. Natural resistance-associated macrophage protein 1 polymorphisms are associated with microscopy-positive tuberculosis. J. Infect. Dis. 2002, 186(4):517-521.
62. Søborg C., Andersen A.B., Range N., Malenganisho W., Friis H., Magnussen P., Temu M.M., Changalucha J., Madsen H.O., Garred P. Influence of candidate susceptibility genes on tuberculosis in a high endemic region. Mol. Immunol. 2007, 44(9):2213-2220.
63. Sun Q., Zhang Q., Xiao H.P., Bai C. Toll-like receptor polymorphisms and tuberculosis susceptibility: a comprehensive meta-analysis. J. Huazhong Univ. Sci. Technolog. Med. Sci. 2015, 35(2):157-168.
64. Tajik N., Salari F., Ghods A.J., Hajilooi M., Radjabzadeh M.F., Mousavi T. Association between recipient ICAM-1K469 allele and renal allograft acute rejection. Int. J. Immunogenet. 2008, 35(1):9-13.
65. Tajik N., Nasiri M.R., Jafari M., Mousavi T., Farnia P., Salekmoghaddam A., Sankian M. Association between Toll-like receptor 4 (TLR4) genetic polymorphisms and susceptibility to pulmonary tuberculosis (article in Persian). Razi J. Med. Sci. 2010, 16(68):19-26.
66. Uitterlinden A.G., Fang Y., van Meurs J.B., Pols H.A., van Leeuwen J.P. Genetics and biology of vitamin D receptor polymorphisms. Gene 2004, 338(2):143-156.
67. Underhill D.M., Ozinsky A., Smith K.D., Aderem A. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc. Natl. Acad. Sci. 1999, 96(25):14459-14463.
68. Vejbaesya S., Chierakul N., Luangtrakool P., Sermduangprateep C. NRAMP1 and TNF-α polymorphisms and susceptibility to tuberculosis in Thais. Respirology 2007, 12(2):202-206.
69. Wang Q., Zhan P., Qiu L.-X., Qian Q., Yu L.-K. TNF-308 gene polymorphism and tuberculosis susceptibility: a meta-analysis involving 18 studies. Mol. Biol. Rep. 2012, 39(4):3393-3400.
70. Wu F., Zhang W., Zhang L., Wu J., Li C., Meng X., Wang X., He P., Zhang J. NRAMP1, VDR, HLA-DRB1, and HLA-DQB1 gene polymorphisms in susceptibility to tuberculosis among the Chinese Kazakh population: A case-control study. BioMed. Res. Int. 2013, 2013.
71. Xue Y., Zhao Z.Q., Wang H.J., Jin L., Liu C.P., Wang Y., Li J.C. Toll-like receptors 2 and 4 gene polymorphisms in a southeastern Chinese population with tuberculosis. Int. J. Immunogenet. 2010, 37(2):135-138.
72. Yoon H.J., Choi J.Y., Kim C.O., Park Y.S., Kim M.S., Kim Y.K., Shin S.Y., Kim J.M., Song Y.G. Lack of Toll-like receptor 4 and 2 polymorphisms in Korean patients with bacteremia. J. Korean Med. Sci. 2006, 21(6):979-982.